Supplementary Table 1
Title: Cardiopulmonary physiology at baseline and after acute pulmonary embolism (group 1)
Variable BASELINE PULMONARY
EMBOLISM
p-value
Hemodynamics
CVP, mmHg 3.91.7 4.41.8 0.3506
SVR, dynes 1499492 1551576 0.8141
PVR/SVR 0.0890.058 0.3350.103 0.0018
Ventilation
Arterial pH 7.480.03 7.400.03 0.0007
PaCO2, kPa 5.290.26 6.690.48 0.0005
PaO2/PaCO2 2.110.50 0.920.23 0.0004
PaO2/FiO2, kPa/% 0.530.11 0.290.06 0.0004
Arterial saturation, % 97.0 [90.0-97.8] 68.6 16.7 0.0078
Arterial O2 content, mL/dL 13.30.7 10.22.3 0.0064
Oxygen delivered, mL/dL 5.61.4 5.41.1 0.8242
PvCO2, kPa 6.530.26 7.460.46 0.0002
PvO2, kPa 4.670.56 3.630.76 0.0034
Mixed venous O2 content, mL/dL 7.61.8 4.71.6 0.0023
Alveolar O2 partial pressure, mmHg 92.53.2 79.45.1 0.0005
Shunt fraction, % 4.8 [3.8-17.4] 43.915.2 0.0078
EtCO2, kPa 5.30.2 4.90.5 0.0189
Right ventricular function
RV ESP, mmHg 286 529 <0.000
1
RV EDP, mmHg 42 51 0.5451
RV ESV, mL 319 4319 0.0958
RV Ea, mmHg/mL 0.4290.140 1.1640.539 0.0028
RV SW, mmHg*mL 2003663 20931037 0.7487
RV dP/dtmax, mmHg/s 31342 441 [399-499] 0.0078
RV dP/dtmin, mmHg/s -34462 -53772 <0.000
1
RV tau, ms 4611 415 0.2741
RV Ees, mmHg/mL 0.580.25 0.850.40 0.0399
RV Eed, mmHg/mL 0.0660.035 0.057 [0.039-0.082] 0.5469
RV PRSW, mmHg 17.033.41 15.7212.20 0.7284
RV PVA/EDV 20.355.56 28.6113.47 0.1405
Left ventricular function
LV ESP, mmHg 9416 9619 0.7844
LV EDP, mmHg 91 91 0.0715
LV ESV, mL 6119 5218 0.0393
LV EF, % AUTO RESP 63 [60-66] 6110 0.7422
LV Ea, mmHg/mL 0.9660.193 1.2210.355 0.0193
LV SW, mmHg*mL 82192022 70871617 0.3093
LV dP/dtmax, mmHg/s 1551246 1605 [1395-2043] 0.3828
LV dP/dtmin, mmHg/s -1911418 -1912520 0.9948
LV tau, ms 373 385 0.9462
LV Ees, mmHg/mL 0.820.55 0.67 [0.56-1.55] 0.1484
LV Eed, mmHg/mL 0.08 [0.07-0.13] 0.090.02 0.3828
LV PRSW, mmHg 53.4913.56 64.0327.25 0.2930
LV PVA/EDV 84.4315.17 94.3227.19 0.4454
LV Ees/Ea 0.840.49 0.850.44 0.9740
Caption: Hemodynamics at baseline and after acute pulmonary embolism induction for group 1, n=8 for all. Data are presented as meanSD or median [interquartile range] where appropriate.
Groups are compared with paired t-test or Wilcoxon signed rank test where appropriate.
Abbreviations: CVP, central venous pressure; SVR, systemic vascular resistance; RV, right ventricular; ESP, end-systolic pressure; EDP, end-diastolic pressure; ESV, end-systolic volume;; EF, ejection fraction; Ea, arterial elastance; SW, stroke work; Ees, end-systolic elastance; Eed, end- diastolic elastance; PRSW, preload recruitable stroke work; PVA, pressure-volume area.
Supplementary Table 2
Title: Effects of increasing fractions of inspired oxygen in acute pulmonary embolism (group 1)
Variable FiO2=21
% (PE)
FiO2=40% FiO2=21
%
FiO2=60% FiO2=21
%
FiO2=100% FiO2=21
%
iNO
Hemodyna mics Heart rate, min-1
719 545* 685 515**** 667 485*** 666 587*
MAP, mmHg
7921 7613 7813 7614 8113 7612 7911 7711
RV CO, mL/min
436720 96
30271225
*
447020 66
28501362
**
443023 11
27241396
*
384322 86
3264148 6
RV SV, mL # 48 [45- 72]
5724 6627 5625 6732 5625 6033 5625
Pulse oximetry,
%
886 100 [99- 100]**
8611 100 [99- 100]***
878 100 [100- 100]**
886 897
mPAP, mmHg
32.96.2 22.05.1**
*
31.86.0 19.54.0**
**
30.56.8 18.13.1** 28.67.2 18.84.1*
**
CVP, mmHg #
4.41.8 4.51.5 5.11.6 4.91.6 3.91.9 4.61.4 3.82.1 3.31.8
PVR, dynes 500188 369185* 464188 337246 487322 315232** 537386 277192 SVR, dynes 155157
6
2128820*
*
148753 6
23791179
*
174297 5
26031337
*
198891 8
2156943
PVR/SVR 0.3350.
103
0.1700.05 4**
0.3150.
079
0.1310.04 3***
0.2790.
081
0.1120.03 4**
0.2540.
083
0.1220.0 49**
Ventilation Arterial pH
#
7.400.0 3
7.390.03 7.410.0 2
7.400.03 7.410.0 2
7.410.02 7.420.0 2
7.410.02
PaCO2, kPa
#
6.690.4 8
6.590.38 6.710.4 7
6.650.43 6.580.5 1
6.500.36 6.580.3 0
6.630.42
PaO2, kPa 6.11
1.32
15.133.34
****
6.731.1 6
27.436.97
***
7.031.3 3
54.7914.4 3***
7.091.1 4
7.470.98
PaO2/PaCO
2
0.920.2 3
2.300.51*
***
1.010.2 1
4.131.05*
**
1.080.2 5
8.422.14*
***
1.080.1 8
1.130.17
PaO2/FiO2, kPa/%
0.290.0 6
0.380.08* 0.320.0 6
0.450.11* 0.340.0 6
0.560.15*
*
0.300.1 0
0.360.05
Arterial saturation,
%
68.6
16.7
97.51.9**
*
74.710.
9
100 [99.9- 100]****
77.312.
0
100 [100- 100]**
78.67.8 81.56.4
Arterial O2
content, mL/dL
10.22.3 14.50.7** 11.21.7 15.20.9**
*
11.31.8 15.70.7**
*
11.51.1 11.81.1
Oxygen delivered, mL/dL
5.41.1 7.01.2 6.10.7 6.70.4* 5.50.8 6.80.6** 5.60.6 5.20.9
Mixed venous PvCO2,kPa#
7.460.4 6
7.660.64 7.580.4 6
7.940.53 7.540.3 4
7.870.49 7.630.4 1
7.670.36
Mixed venous PvO2, kPa
3.630.7 6
5.150.29*
*
3.870.6 3
5.350.21*
*
4.130.5 4
5.710.29*
***
4.230.6 6
4.490.50
Mixed venous saturation,
%
32.712.
4
52.49.8**
*
35.010.
7
57.72.6** 40.010.
2
61.84.0**
*
41.311.
1
45.59.0
Mixed venous O2
content, mL/dL
4.71.6 7.61.3*** 5.11.6 8.40.9** 5.81.5 8.90.9*** 5.91.5 6.61.5
Alveolar O2
partial pressure, mmHg
79.45.1 210.66.3*
***
79.25.2 348.98.9*
***
80.55.5 604.110.7
****
80.43.0 79.94.0
Shunt fraction, %
43.915.
2
7.64.2*** 36.610.
7
5.83.1*** 35.613.
6
7.23.5** 36.28.2 33.29.5
EtCO2, kPa 4.90.5 4.80.3 5.30.4 4,70.2** 5.40.3 4.60.3*** 5.40.3 5.20.2*
Right ventricular function RV ESP, mmHg
529 366*** 529 325*** 5011 314** 469 324**
RV EDP, mmHg
51 51 52 42 52 52 42 42
RV ESV, mL 4319 3511 4517 3310* 4215 329* 3812 289**
RV EDV, mL 15554 11940* 16452 11140** 15051 10642* 12446 9639*
RV EF, % # 5610 5910 567 6111 5812 6211 5713 649
RV Ea, 1.160.5 0.850.43* 1.080.5 0.800.51* 1.130.7 0.56 [0.42- 1.190.8 0.790.44
mmHg/mL 4 * 2 5 1.89] 0 RV SW,
mmHg*mL
209310 37
1617752 226910 41
1513700* 226312 57
1454689 (p0.08)
198712 44
1531695
RV dP/dtmax, mmHg/s
441 [399- 499]
35257* 459102 32755** 455129 31554*** 43580 37771
RV dP/dtmin, mmHg/s
-53772 -41448
***
-52964 -39346
****
-51684 -38141** -49471 -42586*
RV tau, ms 415 434 414 427 416 477 427 4011
RV Ees, mmHg/mL
0.850.4 0
0.690.18 0.820.3 2
0.610.25 0.820.3 5
0.630.23 0.880.4 0
0.800.34
RV Eed, mmHg/mL
0.06 [0.04- 0.08]
0.120.06* 0.080.0 4
0.120.04 (p0.055)
0.100.0 5
0.120.06 0.120.0 5
0.150.07
RV PRSW, mmHg
15.721 2.20
15.464.74 14.916.
05
15.394.33 15.777.
43
15.823.45 18.078.
68
18.704.5 2
RV PVA/EDV
28.611 3.47
23.793.87 28.116.
16
22.814.22 30.968.
81
23.064.65
*
34.216.
38
27.357.4 1*
RV Ees/Ea 1.130.5 5
1.350.50 1.180.5 7
1.420.56*
*
1.010.5 6
1.350.40 1.300.4 7
1.450.36
Left ventricular function LV ESP, mmHg
9619 9310 9311 9511 9610 9610 9611 9511
LV EDP, mmHg
91 102** 91 101** 91 101* 91 91
LV ESV, mL 5218 6512* 5514 7114**** 5811 7711** 679 7312 LV EDV, mL 14725 17026* 15627 18329** 16828 19229* 18523 20230*
LV EF, % 6010 577 617 567 605 566 595 607
LV Ea,
mmHg/mL
1.220.3 6
1.040.20 0.090.2 5
1.020.21 1.050.2 2
0.960.16 0.950.1 7
0.830.17 (p0.053) LV SW,
mmHg*mL
#
708716 17
7386867 740799 1
79011445 813112 13
85141787 897915 42
1000522 53
LV dP/dtmax, mmHg/s
1605 [1395- 2043]
1465257 174242 5
1426283*
*
178949 2
1378212*
*
167627 8
1658276
LV dP/dtmin, mmHg/s
- 191352 0
-1950368 -1877
329
-1971335 -1989
418
-2091352 -2087
468
-2124489
LV tau, ms 385 384 383 392 382 403 383 373 LV Ees,
mmHg/mL 0.67 [0.56- 1.55]
0.550.12 0.680.1 7
0.440.13* 0.640.2 1
0.400.11 (p0.07)
0.630.2 1
0.580.25
LV Eed, mmHg/mL
0.090.0 2
0.070.03 0.080.0 6
0.080.02 0.070.0 2
0.070.02 0.080.0 2
0.070.03
LV PRSW, mmHg
64.032 7.25
54.5210.6 9
56.781 2.64
52.6013.9 8
61.951 7.92
51.2412.4 4
57.70 [50.40- 67-70]
60.0813.
05
LV PVA/EDV
94.322 7.19
83.5316.7 5
91.742 4.34
87.4314.2 6
94.161 6.34
86.7818.9 4
92.711 8.34
86.4217.
38 LV Ees/Ea 0.850.4
4
0.580.15 0.670.2 5
0.460.14 0.680.3 1
0.440.14 0.720.2 9
0.770.37
Caption: Effects of increasing doses of oxygen and inhaled nitric oxide. Data are presented as meanSD or median [interquartile range] where appropriate, n=8 for all. Effects of the interventions were evaluated by one-way ANOVA for repeated measurements using Sidak’s multiple comparisons test comparing each intervention to the FiO2 21% measurement recorded immediately before. Alternatively, Friedman test with Dunn’s multiple comparisons test. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001 vs the FiO2=21% recorded just before each intervention.
#overall ANOVA significant but none in the multiple comparisons test.
Abbreviations: MAP, mean arterial pressure; CO, cardiac output; mPAP, mean pulmonary arterial pressure; CVP, central venous pressure; PVR, pulmonary vascular resistance; SVR, systemic vascular resistance; RV, right ventricular; ESP, end-systolic pressure; EDP, end-diastolic pressure; ESV, end- systolic volume; EDV, end-diastolic volume; EF, ejection fraction; Ea, arterial elastance; SW, stroke work; Ees, end-systolic elastance; Eed, end-diastolic elastance; PRSW, preload recruitable stroke work; PVA, pressure-volume area.
Supplementary Table 3
Title: Cardiopulmonary physiology at baseline and after acute pulmonary embolism (group 2)
Variable BASELINE PULMONARY
EMBOLISM
p-value
Hemodynamics
Heart rate, min-1 4710 6412 0.0002
MAP, mmHg 717 729 0.9004
RV CO, mL/min 3768 [3410-4112] 44831650 0.5469
RV SV, mL 8529 7122 0.2703
Pulse oximetry, % 982 8012 0.0013
mPAP, mmHg 15.42.5 32.95.3 <0.000
1
CVP, mmHg 4.32.0 5.50.9 0.0719
PVR, dynes 15268 471130 0.0002
SVR, dynes 1377362 1356616 0.9296
PVR/SVR 0.120.05 0.380.11 0.0003
Biochemistry
Troponin-I, ng/L 405 [309-517] 798372 0.0078
8-isoprostane, pg/mL 51.713.8 59.517.4 0.2396
Ventilation
Arterial pH 7.470.03 7.390.02 <0.000
1
PaCO2, kPa 5.440.47 6.840.42 <0.000
1
PaO2, kPa 11.991.32 6.601.24 <0.000
1
PaO2/PaCO2 2.220.31 0.970.16 <0.000
1
PaO2/FiO2, kPa/% 0.570.06 0.310.06 <0.000
1
Arterial saturation, % 96.81.9 73.210.0 0.0003
Arterial O2 content, mL/dL 12.90.7 10.41.4 0.0030
Oxygen delivered, mL/dL 5.11.0 5.61.2 0.4290
PvCO2, kPa 6.490.67 7.690.39 0.0028
PvO2, kPa 5.050.78 3.800.70 0.0145
Mixed venous saturation, % 59.313.0 33.711.1 0.0052
Mixed venous O2 content, mL/dL 7.81.6 4.81.6 0.0069
Alveolar O2 partial pressure, mmHg 965 835 <0.000 1
Shunt fraction, % 65 3912 0.0001
EtCO2, kPa 5.30.1 4.70.3 0.0007
Right ventricular function
RV ESP, mmHg 284 485 0.0002
RV EDP, mmHg 52 61 0.4382
RV ESV, mL 3111 43 [41-66] 0.0078
RV EDV, mL 14443 15737 0.4605
RV EF, % 728 556 0.0007
RV Ea, mmHg/mL 0.410.17 0.800.21 0.0011
RV SW, mmHg*mL 1911408 2484954 0.1669
RV dP/dtmax, mmHg/s 36968 51086 0.0015
RV dP/dtmin, mmHg/s -31352 -50076 0.0002
RV tau, ms 54 [49-64] 486 0.0781
RV Ees, mmHg/mL 0.630.28 0.620.18 0.9553
RV Eed, mmHg/mL 0.090.05 0.110.06 0.1785
RV PRSW, mmHg 14.973.81 20.115.67 0.1081
RV PVA/EDV 20.02.9 34.612.6 0.0184
RV Ees/Ea 2.30 [1.18-4.19] 0.970.30 0.0156
Left ventricular function
LV ESP, mmHg 8913 8712 0.7308
LV EDP, mmHg 82 82 0.2882
LV ESV, mL 5512 5319 0.7449
LV EDV, mL 17028 15437 0.1036
LV EF, % 59 [58-73] 5813 0.3828
LV Ea, mmHg/mL 0.930.17 1.260.51 0.0417
LV SW, mmHg*mL 79282284 63432593 0.0658
LV dP/dtmax, mmHg/s 1589347 1597385 0.9580
LV dP/dtmin, mmHg/s -1627498 -1440452 0.2626
LV tau, ms 4511 4610 0.6388
LV Ees, mmHg/mL 1.020.78 1.170.59 0.5481
LV Eed, mmHg/mL 0.100.05 0.090.03 0.6180
LV PRSW, mmHg 48.813.8 53.09.6 0.5372
LV PVA/EDV 86.013.5 80.715.5 0.5458
LV Ees/Ea 0.83 [0.50-2.21] 1.020.51 0.7422
Caption: Hemodynamics at baseline and after acute pulmonary embolism induction for group 2, n=8 for all. Data are presented as meanSD or median [interquartile range] where appropriate.
Groups are compared with paired t-test or Wilcoxon signed rank test where appropriate.
Abbreviations: MAP, mean arterial pressure; CO, cardiac output; mPAP, mean pulmonary arterial pressure; CVP, central venous pressure; PVR, pulmonary vascular resistance; SVR, systemic vascular resistance; RV, right ventricular; ESP, end-systolic pressure; EDP, end-diastolic pressure; ESV, end- systolic volume; EDV, end-diastolic volume; EF, ejection fraction; Ea, arterial elastance; SW, stroke work; Ees, end-systolic elastance; Eed, end-diastolic elastance; PRSW, preload recruitable stroke work; PVA, pressure-volume area.
Supplementary Table 4
Title: Extended effects of increased fraction of inspired oxygen 40% in acute pulmonary embolism (group 2)
Variable FiO2=21% (PE) FiO2=40% (early) FiO2=40%
(late)
FiO2=21% iNO
Hemodynamics
Heart rate, min-1 6412 5110**** 5210 6211‡‡ 5610*
MAP, mmHg 729 725 766 817‡‡‡ 776**
RV CO, mL/min 44831650 38831237 44101253 56052367 44591457
RV SV, mL 7122 7618 8821 9330 8121
Pulse oximetry, % 8012 100 [100-100]*** 100 [100-100] 855‡‡ 856
mPAP, mmHg 335 224**** 204§§ 304‡‡‡‡ 194****
CVP, mmHg 61 51 51 41 41
PVR, dynes 471130 279110** 20366§ 34085‡ 204107 (p0.07)
SVR, dynes 1356616 1489411 1393467 1256493 1423400
PVR/SVR 0.380.11 0.200.09**** 0.160.08§§ 0.290.07‡‡‡‡ 0.150.07****
Ventilation
Arterial pH 7.390.02 7.380.02 7.380.02 7.400.02‡‡ 7.400.02 PaCO2, kPa 6.840.42 6.950.50 6.960.54 6.730.52
(0.07)
6.840.43
PaO2, kPa 6.601.24 16.393.24**** 18.233.56 (p0.052)
7.430.82‡‡‡‡ 7.390.87
PaO2/PaCO2 0.970.16 2.360.42**** 2.620.49 (p0.059)
1.110.12‡‡‡‡ 1.080.13
PaO2/FiO2, kPa/% 0.310.06 0.410.08** 0.460.09 (p0.052)
0.350.04‡‡ 0.350.04
Arterial saturation, % 73.210.0 98.51.2*** 98.80.9 81.94.6‡‡‡‡ 81.34.4 Arterial O2 content,
mL/dL
10.41.4 13.80.5*** 13.60.6 11.20.6‡‡‡‡ 11.10.8
Oxygen delivered, mL/dL
5.61.2 6.30.8 5.71.0 5.61.0 5.51.0
Mixed venous PvCO2, kPa
7.690.39 7.940.41 8.200.35 7.590.69 7.860.45
Mixed venous PvO2, 3.800.70 5.200.48* 5.450.54 4.310.56‡‡ 4.05 [3.90-4.43
kPa
Mixed venous
saturation, %
33.711.1 54.96.4*** 58.87.2 42.28.6‡‡ 41.59.6
Mixed venous O2
content, mL/dL
4.81.6 7.51.0 (p0.055) 7.91.1 5.1 [4.7-6.2]‡ 5.3 [4.6-5.7]
Alveolar O2 partial pressure, mmHg
835 2157**** 2157 846‡‡‡‡ 835
Shunt fraction, % 3912 63**** 54 308‡‡‡‡ 315
EtCO2, kPa 4.70.3 4.60.3 4.80.2§§ 5.50.3‡‡‡‡ 5.10.3***
Right ventricular function
RV ESP, mmHg 485 375** 354§§ 475‡‡‡ 334****
RV EDP, mmHg 61 61 62 61 52
RV ESV, mL 43 [41-66] 4312* 4114 4918‡ 3411**
RV EDV, mL 15737 14929 16041 17546 13929
RV EF, % 556 625** 676 (p0.075) 635 705*
RV Ea, mmHg/mL 0.800.21 0.550.16* 0.450.12 0.580.17‡ 0.470.15 RV SW, mmHg*mL 2484954 2209563 2548695 32671311 2307641*
RV dP/dtmax, mmHg/s 51086 62464 (p0.07) 444114 516 [417- 680]‡‡
459117*
RV dP/dtmin, mmHg/s -50076 -39749*** -40570 -563140 (p0.06)
-38886 (p0.06)
RV tau, ms 486 529 515 508 518
RV Ees, mmHg/mL 0.620.18 0.540.11 0.500.12 0.620.15 0.580.14 RV Eed, mmHg/mL 0.110.06 0.110.04 0.090.04 0.100.05 0.120.04
RV PRSW, mmHg 20.115.67 17.62.0 18.23.4 22.54.8 19.53.3
RV PVA/EDV 34.612.6 27.97.4 25.54.8 34.07.3‡ 26.14.1*
RV Ees/Ea 0.970.30 1.400.34 1.570.43 1.460.32 1.640.34
Left ventricular function
LV ESP, mmHg 8712 908 969§§ 978 948**
LV EDP, mmHg 82 92 91 82 92
LV ESV, mL 5319 6216* 6919 6320‡ 6521
LV EDV, mL 15437 17330* 18929§ 18030‡ 19331*
LV EF, % 5813 5712 5813 5913 6113
LV Ea, mmHg/mL 1.260.51 1.080.36 0.92 [0.79- 1.12]
1.01 [0.85- 1.15]
0.940.30***
LV SW, mmHg*mL 63432593 72692329 85642732§§ 84512523 91612847**
LV dP/dtmax, mmHg/s 1597385 1502163 1543155 1704229 1677195 LV dP/dtmin, mmHg/s -1440452 -1549479 -1708465§ -1737389 -1745455
LV tau, ms 4610 4814 4712 4511 4513
LV Ees, mmHg/mL 1.170.59 0.950.55 1.000.76 0.970.49 0.690.35 LV Eed, mmHg/mL 0.090.03 0.100.04 0.070.03§ 0.080.04 0.070.02 LV PRSW, mmHg 53.09.6 56.718.5 58.011.5 61.910.0 55.010.7
LV PVA/EDV 80.715.5 92.725.3 88.514.3 98.916.8 88.58.1
LV Ees/Ea 1.020.51 1.000.60 0.62 [0.48-
1.68]
0.68 [0.53- 1.53]
0.870.54
Caption: Extended effects of oxygen and inhaled nitric oxide. Data are presented as meanSD or median [interquartile range] where appropriate, n=8 for all. Groups are compared with paired t- test or Wilcoxon signed rank test where appropriate. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 vs the FiO2=21% recorded just before each intervention, ‡p<0.05, ‡‡p<0.01,
‡‡‡p<0.001, ‡‡‡‡p<0.0001 vs FiO2=40% (late), §p<0.05 vs FiO2=40% (early).
Abbreviations: MAP, mean arterial pressure; CO, cardiac output; mPAP, mean pulmonary arterial pressure; CVP, central venous pressure; PVR, pulmonary vascular resistance; SVR, systemic vascular resistance; RV, right ventricular; ESP, end-systolic pressure; EDP, end-diastolic pressure; ESV, end- systolic volume; EDV, end-diastolic volume; EF, ejection fraction; Ea, arterial elastance; SW, stroke work; Ees, end-systolic elastance; Eed, end-diastolic elastance; PRSW, preload recruitable stroke work; PVA, pressure-volume area.